On December 08, 2025, this newsletter featured 5 insider purchases detected from SEC Form 4 filings.
📈 Daily Insider & Cluster Buy Highlights – December 08, 2025
Here are some of the most interesting insider and cluster buying signals from the last 7 days.
⚠️ For information purposes only.
This information is provided for informational purposes only and does not constitute investment advice, financial advice, trading advice, or any other type of advice. All investments carry risk, including the potential loss of principal. Past performance is not indicative of future results. You should consult with a qualified financial advisor, accountant, or other professional before making any investment decisions. The information contained in this newsletter is not intended to be a substitute for professional financial advice.
📊 About Fair Value:
The Fair Value shown for each company is calculated using a Levered Discounted Cash Flow (DCF) model. This method estimates the intrinsic value of a stock by projecting future cash flows and discounting them back to present value, accounting for the company's debt structure. A positive percentage difference indicates the stock may be undervalued relative to this model, while a negative percentage suggests it may be overvalued. Fair value calculations are estimates and should be considered alongside other factors.
🔥 Notable Cluster Buys (≥ $500,000)
No new qualifying cluster buys in the last 7 days.
💼 Notable Individual Insider Buys (≥ $100,000)
Saba Capital Management, L.P.View Chart
10% Owner
ASA Gold & Precious Metals Ltd ($ASA)
Transaction Date: Dec 02, 2025
Shares: 8,078
Purchase Price: $52.82
Purchase Value: $426,680
📈
P&L: 0.3% ($1,292 gain)
Valuation Metrics:
P/E Ratio: 3.8 (below Asset Management avg of 18.1)
Analyst Coverage:
Analyst Rating: A-
📰 Recent News (Last 7 Days):
GlobeNewsWire • Dec 05, 2025
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RE...
GlobeNewsWire • Dec 04, 2025
Oslo, 4 December 2025: Vow ASA (ticker OSE: VOW) and its subsidiary Scanship have received a purchase order from a major European shipyard of EUR 29.6 million. Equipment deliveries will start in July ...
GlobeNewsWire • Dec 03, 2025
Oslo, 3 December 2025 An Extraordinary General Meeting in Ensurge Micropower ASA (the "Company") was held today as an electronic meeting. All items on the agenda were adopted in accordance with the p...
GlobeNewsWire • Dec 01, 2025
Equinor Energy has exercised one year option for Havila Foresight (PSV) until January 2027.Equinor Energy has an option for one year thereafter, until January 2028. Contacts:Chief executive officer Nj...
Director
Nerdy Inc ($NRDY)
Transaction Date: Dec 02, 2025
Shares: 198,100
Purchase Price: $1.26
Purchase Value: $249,606
📈
P&L: 4.8% ($11,886 gain)
Valuation Metrics:
P/E Ratio: -3.8 (negative - Software - Application avg: 55.2)
Analyst Coverage:
Analyst Rating: D+
Avg Price Target: $1.00 (-24.2% vs current)
📰 Recent News (Last 7 Days):
Zacks Investment Research • Dec 01, 2025
These school stocks are thriving as education pivots toward career-ready skills and digital learning, innovative teaching platforms - LOPE, MH, ATGE, PRDO and NRDY.
N/A
SmartRent, Inc ($SMRT)
Transaction Date: Dec 05, 2025
Shares: 124,086
Purchase Price: $1.91
Purchase Value: $237,401
📈
P&L: 3.0% ($7,048 gain)
Valuation Metrics:
P/E Ratio: -39.4 (negative - Software - Application avg: 55.2)
Analyst Coverage:
Analyst Rating: B
Avg Price Target: $3.81 (+93.4% vs current)
Director
Bridger Aerospace Group Holdings, Inc ($BAER)
Transaction Date: Dec 03, 2025
Shares: 100,000
Purchase Price: $1.80
Purchase Value: $180,070
📈
P&L: 1.1% ($1,930 gain)
Analyst Coverage:
Analyst Rating: B+
Avg Price Target: $5.25 (+188.5% vs current)
Casdin Partners Master Fund, L.P.View Chart
Director
STANDARD BIOTOOLS INC ($LAB)
Transaction Date: Dec 02, 2025
Shares: 125,000
Purchase Price: $1.42
Purchase Value: $177,512
📈
P&L: 0.7% ($1,237 gain)
Valuation Metrics:
P/E Ratio: -6.5 (negative - Medical Devices avg: 38.1)
Analyst Coverage:
Analyst Rating: C
Avg Price Target: $3.25 (+127.3% vs current)
⚠️ For information purposes only.
This information is provided for informational purposes only and does not constitute investment advice, financial advice, trading advice, or any other type of advice. All investments carry risk, including the potential loss of principal. Past performance is not indicative of future results. You should consult with a qualified financial advisor, accountant, or other professional before making any investment decisions. The information contained in this newsletter is not intended to be a substitute for professional financial advice.